Kenvue Inc (KVUE)

$19.08 +0.28 (1.46%)
Market Cap 36.09B
Revenue (ttm) 15.12B
Net Income (ttm) 1.47B
EPS (ttm) N/A
PE Ratio 16.27
Forward PE 16.79
Profit Margin 9.72%
Debt to Equity Ratio 0.67
Volume 15,029,644
Avg Vol 20,227,355
Day's Range N/A - N/A
Shares Out 1.92B
Stochastic %K 14%
Beta 0.47
Analysts Sell
Price Target $19.50

Company Profile

Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and bod...

Industry: Household & Personal Products
Sector: Consumer Defensive
Phone: 908 874 1200
Address:
1 Kenvue Way, Summit, United States
TragicRain
TragicRain Aug. 19 at 5:22 PM
$KVUE Essity Strikes Agreement To Acquire Kenvue's Feminine Care Operations In Brazil For $284M
0 · Reply
USAEquityResearch
USAEquityResearch Aug. 19 at 10:44 AM
$KVUE 📊 USAEquityResearch ▲ 18.80 (+0.05%) Trend: Cautiously bearish ↘️ RSI (14): 36.9 — weak momentum, approaching oversold MACD: bearish, below signal line Volume: above average 📌 Key Levels Resistance: 19.57 Support: 18.69 20-MA: 19.06 | 50-MA: 18.74 Educational content only. Not financial advice.
0 · Reply
ValuationPolice91
ValuationPolice91 Aug. 17 at 10:25 PM
$KVUE this brand owns Neutrogena. Which dropped Hayden P for suffering with depression $SPY
0 · Reply
Spotterus
Spotterus Aug. 13 at 7:14 PM
$KVUE have a 1000 kvue shares at 15.98. I have no interest in kmb, so if the merger hits i get $3500 and 146 kmb shares. For me it looks better to sell kvue above $19.50 and not dealing with the merger and having to sell 146 kmb shares for ???. again i have zero interest in kmb.
0 · Reply
Snipertradesexpert
Snipertradesexpert Aug. 13 at 3:02 PM
$KVUE 🧴 $19.5 14 AUG 26 (W) CALL 100 $0.13 ➡️ $0.06 ❎ 53% LOSS! ❌
0 · Reply
Tokenaxiss
Tokenaxiss Aug. 13 at 2:53 PM
$KVUE $KVUE 🧴 $19.5 14 AUG 26 (W) CALL 100 $0.13 ➡️ $0.06 ❎ 53% LOSS! ❌
0 · Reply
LUXtrades0
LUXtrades0 Aug. 13 at 2:53 PM
$KVUE 🧴 $19.5 14 AUG 26 (W) CALL 100 $0.13 ➡️ $0.06 ❎ 53% LOSS! ❌
0 · Reply
Strikertrade
Strikertrade Aug. 13 at 2:53 PM
$KVUE $19.5 14 AUG 26 (W) CALL 100 $0.13➡️$0.06 53% LOSS!
0 · Reply
Alphatrades09
Alphatrades09 Aug. 13 at 2:53 PM
$KVUE $0.06 here. -53% loss. ❌
0 · Reply
Blockwave01
Blockwave01 Aug. 13 at 2:52 PM
$KVUE $19.5 14 AUG 26 (W) CALL 100 $0.13 ➡️ $0.06 ❎ 53% LOSS!
0 · Reply
Latest News on KVUE
Kimberly-Clark Appoints Suzana Blades as Senior Vice President and General Counsel

Aug 13, 2026, 9:25 AM EDT - 6 days ago

Kimberly-Clark Appoints Suzana Blades as Senior Vice President and General Counsel

KMB

Kenvue Quarterly report: Q2 2026

Aug 6, 2026, 9:30 AM EDT - 13 days ago

Kenvue Quarterly report: Q2 2026

Kenvue Earnings release: Q2 2026

Aug 6, 2026, 9:30 AM EDT - 13 days ago

Kenvue Earnings release: Q2 2026

Kenvue misses quarterly estimates as inflation, tariffs squeeze margins

Aug 6, 2026, 7:47 AM EDT - 13 days ago

Kenvue misses quarterly estimates as inflation, tariffs squeeze margins

Kenvue Posts Higher Profit, Sales as Turnaround Continues

Aug 6, 2026, 7:38 AM EDT - 13 days ago

Kenvue Posts Higher Profit, Sales as Turnaround Continues

Kenvue Reports Second Quarter 2026 Results

Aug 6, 2026, 6:45 AM EDT - 13 days ago

Kenvue Reports Second Quarter 2026 Results

Drugmakers, retailers must face 'maximum strength' claim in decongestant false ad litigation in US

Jul 30, 2026, 4:20 PM EDT - 19 days ago

Drugmakers, retailers must face 'maximum strength' claim in decongestant false ad litigation in US

COST CVS GSK HLN PG TGT WMT

Kenvue Increases Quarterly Cash Dividend

Jul 29, 2026, 6:45 AM EDT - 21 days ago

Kenvue Increases Quarterly Cash Dividend

US FDA approves over-the-counter Tylenol combination pill for pain relief

Jul 24, 2026, 12:00 PM EDT - 26 days ago

US FDA approves over-the-counter Tylenol combination pill for pain relief

Kenvue to Announce Second Quarter 2026 Results on August 6, 2026

Jul 23, 2026, 6:45 AM EDT - 27 days ago

Kenvue to Announce Second Quarter 2026 Results on August 6, 2026

US appeals court revives private lawsuits linking Tylenol to autism, ADHD

Jul 13, 2026, 10:54 AM EDT - 5 weeks ago

US appeals court revives private lawsuits linking Tylenol to autism, ADHD

Wall Street hated these 15 stocks. Then their earnings proved the analysts wrong.

Jun 3, 2026, 8:10 AM EDT - 2 months ago

Wall Street hated these 15 stocks. Then their earnings proved the analysts wrong.

AES ARW BAX EXP EXPD HPQ IESC

Kenvue Transcript: AGM 2026

May 21, 2026, 9:00 AM EDT - 3 months ago

Kenvue Transcript: AGM 2026

Kenvue Earnings release: Q1 2026

May 7, 2026, 9:30 AM EDT - 3 months ago

Kenvue Earnings release: Q1 2026

Kenvue Quarterly report: Q1 2026

May 7, 2026, 9:30 AM EDT - 3 months ago

Kenvue Quarterly report: Q1 2026

Kenvue beats first-quarter estimates amid pending acquisition by Kimberly-Clark

May 7, 2026, 7:15 AM EDT - 3 months ago

Kenvue beats first-quarter estimates amid pending acquisition by Kimberly-Clark

KMB

Kenvue Reports First Quarter 2026 Results

May 7, 2026, 6:30 AM EDT - 3 months ago

Kenvue Reports First Quarter 2026 Results

Kenvue Declares Quarterly Cash Dividend

Apr 29, 2026, 6:45 AM EDT - 4 months ago

Kenvue Declares Quarterly Cash Dividend

This 5-Stock “Super Staples” Portfolio Yields Up To 11.3%

Apr 26, 2026, 9:40 AM EDT - 4 months ago

This 5-Stock “Super Staples” Portfolio Yields Up To 11.3%

CAG CALM FLO KMB NOMD

Kenvue to Announce First Quarter 2026 Results on May 7, 2026

Apr 23, 2026, 4:32 PM EDT - 4 months ago

Kenvue to Announce First Quarter 2026 Results on May 7, 2026

Kimberly-Clark Details Structure, Leadership Team Following Kenvue Deal

Apr 15, 2026, 10:01 AM EDT - 4 months ago

Kimberly-Clark Details Structure, Leadership Team Following Kenvue Deal

KMB

Kimberly-Clark retains Urdaneta as CFO of combined company after $40-billion Kenvue deal

Apr 15, 2026, 9:52 AM EDT - 4 months ago

Kimberly-Clark retains Urdaneta as CFO of combined company after $40-billion Kenvue deal

KMB

Kimberly-Clark Announces Post-Closing Organizational Structure and Identifies Key Leadership

Apr 15, 2026, 8:55 AM EDT - 4 months ago

Kimberly-Clark Announces Post-Closing Organizational Structure and Identifies Key Leadership

KMB

Tylenol in pregnancy not linked with autism, Danish study finds

Apr 13, 2026, 2:09 PM EDT - 4 months ago

Tylenol in pregnancy not linked with autism, Danish study finds

Kenvue Proxy statement: Proxy filing

Apr 8, 2026, 8:00 AM EDT - 4 months ago

Kenvue Proxy statement: Proxy filing

Kenvue Proxy statement: Proxy filing

Apr 8, 2026, 8:00 AM EDT - 4 months ago

Kenvue Proxy statement: Proxy filing

Tylenol use among women dropped after Trump tied it to autism

Mar 6, 2026, 12:43 PM EST - 5 months ago

Tylenol use among women dropped after Trump tied it to autism

Judge rejects Kenvue bid to dismiss Texas lawsuit over Tylenol

Feb 26, 2026, 11:14 AM EST - 6 months ago

Judge rejects Kenvue bid to dismiss Texas lawsuit over Tylenol

Kenvue to Cut 3.5% of Workforce Ahead of Kimberly-Clark Deal

Feb 17, 2026, 5:50 PM EST - 6 months ago

Kenvue to Cut 3.5% of Workforce Ahead of Kimberly-Clark Deal

Kenvue beats quarterly estimates, announces job cuts amid Kimberly-Clark acquisition

Feb 17, 2026, 5:42 PM EST - 6 months ago

Kenvue beats quarterly estimates, announces job cuts amid Kimberly-Clark acquisition

KMB

Kenvue Reports Fourth Quarter and Full Year 2025 Results

Feb 17, 2026, 4:45 PM EST - 6 months ago

Kenvue Reports Fourth Quarter and Full Year 2025 Results

Kenvue Annual report: Q4 2025

Feb 17, 2026, 4:00 PM EST - 6 months ago

Kenvue Annual report: Q4 2025

Kenvue Earnings release: Q4 2025

Feb 17, 2026, 4:00 PM EST - 6 months ago

Kenvue Earnings release: Q4 2025

Kenvue to Announce Fourth Quarter and Full Year 2025 Results on February 17, 2026

Feb 4, 2026, 6:45 AM EST - 7 months ago

Kenvue to Announce Fourth Quarter and Full Year 2025 Results on February 17, 2026

Kimberly-Clark and Kenvue Shareholders Overwhelmingly Approve Kimberly-Clark's Acquisition of Kenvue

Jan 29, 2026, 9:27 AM EST - 7 months ago

Kimberly-Clark and Kenvue Shareholders Overwhelmingly Approve Kimberly-Clark's Acquisition of Kenvue

KMB

Kenvue Transcript: AGM 2026

Jan 29, 2026, 9:00 AM EST - 7 months ago

Kenvue Transcript: AGM 2026

Kimberly-Clark Posts Higher Profit Ahead of Kenvue Vote

Jan 27, 2026, 6:40 AM EST - 7 months ago

Kimberly-Clark Posts Higher Profit Ahead of Kenvue Vote

KMB

Paracetamol/Tylenol in pregnancy is safe, says research prompted by Trump autism claims

Jan 16, 2026, 6:32 PM EST - 7 months ago

Paracetamol/Tylenol in pregnancy is safe, says research prompted by Trump autism claims

ISS recommends shareholders approve Kimberly-Clark's planned Kenvue deal

Jan 16, 2026, 10:00 AM EST - 7 months ago

ISS recommends shareholders approve Kimberly-Clark's planned Kenvue deal

KMB

Kenvue Proxy statement: Proxy Filing

Dec 16, 2025, 7:00 AM EST - 8 months ago

Kenvue Proxy statement: Proxy Filing

US appeals court to weigh reviving cases over Tylenol and autism

Nov 17, 2025, 6:07 AM EST - 9 months ago

US appeals court to weigh reviving cases over Tylenol and autism

Texas state judge won't block Kenvue from paying dividend, company lawyer says

Nov 14, 2025, 12:42 PM EST - 9 months ago

Texas state judge won't block Kenvue from paying dividend, company lawyer says

Judge to weigh if Texas AG can block Kenvue dividend over Tylenol

Nov 14, 2025, 6:05 AM EST - 9 months ago

Judge to weigh if Texas AG can block Kenvue dividend over Tylenol

Texas seeks to block Kenvue dividend amid Tylenol lawsuit

Nov 6, 2025, 8:06 AM EST - 10 months ago

Texas seeks to block Kenvue dividend amid Tylenol lawsuit

The CEO Behind Kimberly-Clark's $40 Billion Gamble on Tylenol Maker

Nov 3, 2025, 10:00 PM EST - 10 months ago

The CEO Behind Kimberly-Clark's $40 Billion Gamble on Tylenol Maker

KMB

Kenvue Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Kenvue Inc. - KVUE

Nov 3, 2025, 7:11 PM EST - 10 months ago

Kenvue Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Kenvue Inc. - KVUE

KMB

Kimberly-Clark CEO talks Kenvue acquisition, calls Tylenol brand 'resilient'

Nov 3, 2025, 6:40 PM EST - 10 months ago

Kimberly-Clark CEO talks Kenvue acquisition, calls Tylenol brand 'resilient'

KMB

Kenvue's legal risks loom over planned acquisition by Kimberly-Clark

Nov 3, 2025, 5:20 PM EST - 10 months ago

Kenvue's legal risks loom over planned acquisition by Kimberly-Clark

KMB

S&P 500 Gains & Losses Today: Amazon Stock Jumps After OpenAI Deal; Kimberly-Clark Acquires Kenvue

Nov 3, 2025, 5:15 PM EST - 10 months ago

S&P 500 Gains & Losses Today: Amazon Stock Jumps After OpenAI Deal; Kimberly-Clark Acquires Kenvue

AMZN KMB

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Kenvue Inc.

Nov 3, 2025, 4:58 PM EST - 10 months ago

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Kenvue Inc.

KMB

Kimberly-Clark's $50 billion leap into health and beauty tests investor faith

Nov 3, 2025, 4:39 PM EST - 10 months ago

Kimberly-Clark's $50 billion leap into health and beauty tests investor faith

KMB

KVUE stock price: Kenvue soars 19% today, Kimberly-Clark deal offers a win after Trump Tylenol drama

Nov 3, 2025, 4:01 PM EST - 10 months ago

KVUE stock price: Kenvue soars 19% today, Kimberly-Clark deal offers a win after Trump Tylenol drama

KMB

Explainer: Is Tylenol safe to take during pregnancy?

Nov 3, 2025, 3:29 PM EST - 10 months ago

Explainer: Is Tylenol safe to take during pregnancy?

KMB

Kenvue deal could double Kimberly-Clark stock's multiple: find out more

Nov 3, 2025, 12:37 PM EST - 10 months ago

Kenvue deal could double Kimberly-Clark stock's multiple: find out more

KMB

Kimberly-Clark to buy Tylenol maker Kenvue in massive consumer merger

Nov 3, 2025, 12:01 PM EST - 10 months ago

Kimberly-Clark to buy Tylenol maker Kenvue in massive consumer merger

KMB

Kimberly-Clark Is Buying Tylenol Maker Kenvue for Nearly $49B. Here's What You Need to Know

Nov 3, 2025, 11:40 AM EST - 10 months ago

Kimberly-Clark Is Buying Tylenol Maker Kenvue for Nearly $49B. Here's What You Need to Know

KMB

Kimberly-Clark Buying Tylenol Maker Kenvue in $40 Billion Deal

Nov 3, 2025, 11:18 AM EST - 10 months ago

Kimberly-Clark Buying Tylenol Maker Kenvue in $40 Billion Deal

KMB

Kimberly-Clark buys Tylenol maker Kenvue in a cash and stock deal for $48.7 billion

Nov 3, 2025, 10:44 AM EST - 10 months ago

Kimberly-Clark buys Tylenol maker Kenvue in a cash and stock deal for $48.7 billion

KMB

TragicRain
TragicRain Aug. 19 at 5:22 PM
$KVUE Essity Strikes Agreement To Acquire Kenvue's Feminine Care Operations In Brazil For $284M
0 · Reply
USAEquityResearch
USAEquityResearch Aug. 19 at 10:44 AM
$KVUE 📊 USAEquityResearch ▲ 18.80 (+0.05%) Trend: Cautiously bearish ↘️ RSI (14): 36.9 — weak momentum, approaching oversold MACD: bearish, below signal line Volume: above average 📌 Key Levels Resistance: 19.57 Support: 18.69 20-MA: 19.06 | 50-MA: 18.74 Educational content only. Not financial advice.
0 · Reply
ValuationPolice91
ValuationPolice91 Aug. 17 at 10:25 PM
$KVUE this brand owns Neutrogena. Which dropped Hayden P for suffering with depression $SPY
0 · Reply
Spotterus
Spotterus Aug. 13 at 7:14 PM
$KVUE have a 1000 kvue shares at 15.98. I have no interest in kmb, so if the merger hits i get $3500 and 146 kmb shares. For me it looks better to sell kvue above $19.50 and not dealing with the merger and having to sell 146 kmb shares for ???. again i have zero interest in kmb.
0 · Reply
Snipertradesexpert
Snipertradesexpert Aug. 13 at 3:02 PM
$KVUE 🧴 $19.5 14 AUG 26 (W) CALL 100 $0.13 ➡️ $0.06 ❎ 53% LOSS! ❌
0 · Reply
Tokenaxiss
Tokenaxiss Aug. 13 at 2:53 PM
$KVUE $KVUE 🧴 $19.5 14 AUG 26 (W) CALL 100 $0.13 ➡️ $0.06 ❎ 53% LOSS! ❌
0 · Reply
LUXtrades0
LUXtrades0 Aug. 13 at 2:53 PM
$KVUE 🧴 $19.5 14 AUG 26 (W) CALL 100 $0.13 ➡️ $0.06 ❎ 53% LOSS! ❌
0 · Reply
Strikertrade
Strikertrade Aug. 13 at 2:53 PM
$KVUE $19.5 14 AUG 26 (W) CALL 100 $0.13➡️$0.06 53% LOSS!
0 · Reply
Alphatrades09
Alphatrades09 Aug. 13 at 2:53 PM
$KVUE $0.06 here. -53% loss. ❌
0 · Reply
Blockwave01
Blockwave01 Aug. 13 at 2:52 PM
$KVUE $19.5 14 AUG 26 (W) CALL 100 $0.13 ➡️ $0.06 ❎ 53% LOSS!
0 · Reply
Alphatrades09
Alphatrades09 Aug. 13 at 2:28 PM
$KVUE below my fill for those who always want to get these below my average
0 · Reply
Strikertrade
Strikertrade Aug. 13 at 2:25 PM
$KVUE 14 AUG 26 $19.5 CALL $0.13 INSIDE BAR + HIGH CONFIDENCE + ADDED HEAVY
0 · Reply
Alphatrades09
Alphatrades09 Aug. 13 at 2:24 PM
$KVUE 19.5C 8/14 @ 0.13 HERE
0 · Reply
Tokenaxiss
Tokenaxiss Aug. 13 at 2:24 PM
$KVUE 14 AUG 26 $19.5 CALL $0.13
0 · Reply
Blockwave01
Blockwave01 Aug. 13 at 2:24 PM
$KVUE 14 AUG 26 $19.5 CALL $0.13 INSIDE BAR + HIGH CONFIDENCE + ADDED HEAVY
0 · Reply
ApexEquityVault
ApexEquityVault Aug. 13 at 2:24 PM
$KVUE 14 AUG 26 $19.5 CALL $0.13 INSIDE BAR + ADDED HEAVY (NFA)
0 · Reply
Alphatrades09
Alphatrades09 Aug. 13 at 2:24 PM
$KVUE 19.5C 8/14 @ 0.13
0 · Reply
LUXtrades0
LUXtrades0 Aug. 13 at 2:24 PM
$KVUE 14 AUG 26 $19.5 CALL $0.13 🤾🏼‍♂️
0 · Reply
Snipertradesexpert
Snipertradesexpert Aug. 13 at 2:23 PM
$KVUE 14 AUG 26 $19.5 CALL $0.13
0 · Reply
Big_dip_flip
Big_dip_flip Aug. 11 at 7:35 PM
$KVUE thinking it will go back up and then some but how much will it drop tomorrow?
1 · Reply
Big_dip_flip
Big_dip_flip Aug. 11 at 7:34 PM
$KVUE what is everyone’s thoughts on flipping puts for tomorrow since the dividend will be locked in which automatically drives the price down on Wednesday
0 · Reply
NebulaNexus
NebulaNexus Aug. 6 at 3:50 PM
$KVUE came in just below expectations, and the market noticed. The miss was modest, but with defensive names trading at richer valuations, even small disappointments can weigh on sentiment. The focus now shifts to whether growth and margins stabilize over the next few quarters.
0 · Reply